Karen L. O`Malley, Ph.D.

Professor
Neuroscience

Neurosciences Program
Molecular Cell Biology Program

  • 314-362-7087

  • 314-362-7090

  • 314-362-3446

  • 8108

  • 908 McDonnell Medical Sciences Building

  • omalleyk@wustl.edu

  • http://neurosci.wustl.edu/People/Faculty/karen-omalley

  • apoptosis, bioinformatics, gene expression, neurobiology, signal transduction, transgenic

  • Mechanisms underlying the specification, regulation, and neurodegeneration of dopaminergic and glutamatergic systems

Research Abstract:

My laboratory is interested in the molecular and cellular bases of neurological and neuropsychiatric disorders. For example, atypical dopamine function has been implicated in disorders such as Parkinson’s disease, drug addiction, affective disorders and Schizophrenia. A current lab emphasis is in determining the mechanisms of cell death in Parkinson’s disease. We are examining the biochemical and genetic events associated with parkinsonian models in vivo and in primary cultures of dopaminergic neurons. Microarray analysis is being used to globally determine which signaling pathways are utilized by parkinsonism-inducing agents as well as the known mutations. Enhanced understanding of the common and distinct cell death mechanisms associated with these toxins and genes may identify unique cellular targets for the generation of novel therapeutic interventions. In other studies, we are using homologous recombination and recombineering to create animal models in which gene expression in dopaminergic cells is spatially and temporally controlled. Our overall goal is to create an inducible animal model of Parkinson’s disease.

Another interest of the lab relates to signal transduction mediated by metabotropic glutamate receptors. Widely expressed throughout the CNS, metabotropic glutamate receptors play important roles modulating neuronal excitability during critical processes such as development, synaptic plasticity and learning. Recently we found that these receptors can be expressed on the cell surface as well as nuclear membranes where they mediate increased calcium levels. Current efforts are aimed at deducing how receptors are activated, how they are targeted to nuclear membranes, and what the long-term consequences of receptor activation are.

Selected Publications:

Hasbani DM, O'Malley KL. Wld(S) mice are protected against the Parkinsonian mimetic MPTP. Exp Neurol 2006 202:93-99.

Holtz WA, Turetzky JM, Jong YJ, O'Malley KL. Oxidative stress-triggered unfolded protein response is upstream of intrinsic cell death evoked by parkinsonian mimetics. J Neurochem 2006 99:54-69.

Hasbani DM, Perez FA, Palmiter RD, O'Malley KL. Dopamine depletion does not protect against acute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity in vivo. J Neurosci 2005 25:9428-9433.

Jong YJ, Kumar V, Kingston AE, Romano C, O'Malley KL. Functional metabotropic glutamate receptors on nuclei from brain and primary cultured striatal neurons. Role of transporters in delivering ligand. J Biol Chem 2005 280:30469-30480.

Holtz WA, O'Malley KL. Parkinsonian mimetics induce aspects of unfolded protein response in death of dopaminergic neurons. J Biol Chem 2003 278:19367-19377.

Last Updated: 8/4/2011 11:33:26 AM

Back To Top

Follow us: